Rafferty Asset Management, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,866,958
-34.8%
904,403
+2.2%
0.02%
-32.0%
Q2 2023$4,396,318
+31.4%
884,571
+30.7%
0.02%
+8.7%
Q1 2023$3,344,563
-29.7%
677,037
-10.5%
0.02%
-42.5%
Q4 2022$4,758,435
-4.2%
756,508
+64.5%
0.04%
-24.5%
Q3 2022$4,966,000
+96.4%
459,831
+107.3%
0.05%
+130.4%
Q2 2022$2,529,000
-51.1%
221,859
-60.9%
0.02%
-25.8%
Q1 2022$5,174,000
+17.4%
567,918
+92.3%
0.03%
+34.8%
Q4 2021$4,407,000
+30.6%
295,379
+125.0%
0.02%0.0%
Q3 2021$3,374,000
+29.4%
131,281
+31.4%
0.02%
+43.8%
Q2 2021$2,607,000
-14.7%
99,943
+15.4%
0.02%
-23.8%
Q1 2021$3,056,000
+256.2%
86,583
+154.7%
0.02%
+162.5%
Q4 2020$858,000
-62.9%
33,998
-44.5%
0.01%
-71.4%
Q3 2020$2,311,000
+136.3%
61,277
+168.2%
0.03%
+100.0%
Q2 2020$978,000
-22.6%
22,849
-53.0%
0.01%
-26.3%
Q4 2019$1,263,000
-22.0%
48,615
-18.2%
0.02%
-24.0%
Q3 2019$1,620,000
-21.1%
59,426
-22.3%
0.02%
-30.6%
Q2 2019$2,054,000
+29.6%
76,483
+39.5%
0.04%
+38.5%
Q1 2019$1,585,00054,8330.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders